{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:58:18Z","timestamp":1793735898300,"version":"4.6.1"},"reference-count":56,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Cognitive impairment represents a core and prodromal clinical feature of cerebral amyloid angiopathy (CAA). We sought to assess specific cognitive domains which are mainly affected among patients with CAA and to investigate probable associations with neuroimaging markers and Cerebrospinal Fluid (CSF) biomarkers. Methods: Thirty-five patients fulfilling the Boston Criteria v1.5 or v2.0 for the diagnosis of probable\/possible CAA were enrolled in this prospective cohort study. Brain Magnetic Resonance Imaging and CSF biomarker data were collected. Every eligible participant underwent a comprehensive neurocognitive assessment. Spearman\u2019s rank correlation tests were used to identify possible relationships between the Addenbrooke\u2019s Cognitive Examination\u2014Revised (ACE-R) sub-scores and other neurocognitive test scores and the CSF biomarker and neuroimaging parameters among CAA patients. Moreover, linear regression analyses were used to investigate the effects of CSF biomarkers on the ACE-R total score and Mini-Mental State Examination (MMSE) score, based on the outcomes of univariate analyses. Results: Cognitive impairment was detected in 80% of patients, and 60% had a coexistent Alzheimer\u2019s disease (AD) pathology based on CSF biomarker profiles. Notable correlations were identified between increased levels of total tau (t-tau) and phosphorylated tau (p-tau) and diminished performance in terms of overall cognitive function, especially memory. In contrast, neuroimaging indicators, including lobar cerebral microbleeds and superficial siderosis, had no significant associations with cognitive scores. Among the CAA patients, those without AD had superior neurocognitive test performance, with significant differences observed in their ACE-R total scores and memory sub-scores. Conclusions: The significance of tauopathy in cognitive impairment associated with CAA may be greater than previously imagined, underscoring the necessity for additional exploration of the non-hemorrhagic facets of the disease and new neuroimaging markers.<\/jats:p>","DOI":"10.3390\/jcm13237427","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T03:44:47Z","timestamp":1733456687000},"page":"7427","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cognitive Impairment in Cerebral Amyloid Angiopathy: A Single-Center Prospective Cohort Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-2610","authenticated-orcid":false,"given":"Aikaterini","family":"Theodorou","sequence":"first","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Athanasaki","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3224-3053","authenticated-orcid":false,"given":"Konstantinos","family":"Melanis","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7488-4425","authenticated-orcid":false,"given":"Ioanna","family":"Pachi","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2865-048X","authenticated-orcid":false,"given":"Angeliki","family":"Sterpi","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Koropouli","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7002-9795","authenticated-orcid":false,"given":"Eleni","family":"Bakola","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chondrogianni","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Ioanna","family":"Stefanou","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"},{"name":"Department of Neurology & Stroke, Eberhard-Karls University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"},{"name":"Hertie Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4082-8061","authenticated-orcid":false,"given":"Efthimios","family":"Vasilopoulos","sequence":"additional","affiliation":[{"name":"First Department of Psychiatry, \u201cAiginition\u201d Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Kouzoupis","sequence":"additional","affiliation":[{"name":"First Department of Psychiatry, \u201cAiginition\u201d Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-3060","authenticated-orcid":false,"given":"Georgios P.","family":"Paraskevas","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-3797","authenticated-orcid":false,"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"},{"name":"Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0774-3613","authenticated-orcid":false,"given":"Elias","family":"Tzavellas","sequence":"additional","affiliation":[{"name":"First Department of Psychiatry, \u201cAiginition\u201d Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/brain\/awx047","article-title":"Emerging concepts in sporadic cerebral amyloid angiopathy","volume":"140","author":"Charidimou","year":"2017","journal-title":"Brain"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Keage, H.A., Carare, R.O., Friedland, R.P., Ince, P.G., Love, S., Nicoll, J.A., Wharton, S.B., Weller, R.O., and Brayne, C. (2009). Population studies of sporadic cerebral amyloid angiopathy and dementia: A systematic review. BMC Neurol., 9.","DOI":"10.1186\/1471-2377-9-3"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","article-title":"Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy","volume":"74","author":"Linn","year":"2010","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: A multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Theodorou, A., Palaiodimou, L., Papagiannopoulou, G., Kargiotis, O., Psychogios, K., Safouris, A., Bakola, E., Chondrogianni, M., Kotsali-Peteinelli, V., and Melanis, K. (2023). Clinical Characteristics, Neuroimaging Markers, and Outcomes in Patients with Cerebral Amyloid Angiopathy: A Prospective Cohort Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175591"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/STROKEAHA.121.035836","article-title":"Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis","volume":"53","author":"Malhotra","year":"2022","journal-title":"Stroke"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(23)00114-X","article-title":"Progression of cerebral amyloid angiopathy: A pathophysiological framework","volume":"22","author":"Koemans","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1007\/s10072-024-07399-7","article-title":"Cognitive and psychological characteristics in patients with Cerebral Amyloid Angiopathy: A literature review","volume":"45","author":"Schiavolin","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-150890","article-title":"Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit","volume":"52","author":"Xiong","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-190346","article-title":"Predictors for Late Post-Intracerebral Hemorrhage Dementia in Patients with Probable Cerebral Amyloid Angiopathy","volume":"71","author":"Xiong","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/STROKEAHA.118.022280","article-title":"Cerebral Cortical Microinfarcts on Magnetic Resonance Imaging and Their Association with Cognition in Cerebral Amyloid Angiopathy","volume":"49","author":"Xiong","year":"2018","journal-title":"Stroke"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0271678X17700435","article-title":"Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage","volume":"38","author":"Xiong","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1975","DOI":"10.1212\/WNL.0000000000011745","article-title":"Association of Memory Impairment with Concomitant Tau Pathology in Patients with Cerebral Amyloid Angiopathy","volume":"96","author":"Schoemaker","year":"2021","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-160927","article-title":"Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study","volume":"56","author":"Valenti","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vandenbroucke, J.P., von Elm, E., Altman, D.G., G\u00f8tzsche, P.C., Mulrow, C.D., Pocock, S.J., Poole, C., Schlesselman, J.J., and Egger, M. (2007). STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040297"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/STROKEAHA.119.024843","article-title":"Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy","volume":"50","author":"Pasi","year":"2019","journal-title":"Stroke"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/brain\/awv162","article-title":"Cortical superficial siderosis: Detection and clinical significance in cerebral amyloid angiopathy and related conditions","volume":"138","author":"Charidimou","year":"2015","journal-title":"Brain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/STROKEAHA.115.008778","article-title":"Contribution of convexal subarachnoid hemorrhage to disease progression in cerebral amyloid angiopathy","volume":"46","author":"Beitzke","year":"2015","journal-title":"Stroke"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/01.wnl.0000438225.02729.04","article-title":"White matter perivascular spaces: An MRI marker in pathology-proven cerebral amyloid angiopathy?","volume":"82","author":"Charidimou","year":"2014","journal-title":"Neurology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/WNL.0000000000002362","article-title":"White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy","volume":"86","author":"Charidimou","year":"2016","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10072-005-0443-4","article-title":"The Frontal Assessment Battery (FAB): Normative values in an Italian population sample","volume":"26","author":"Appollonio","year":"2005","journal-title":"Neurol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp.64.5.588","article-title":"CLOX: An executive clock drawing task","volume":"64","author":"Royall","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/gps.1610","article-title":"The Addenbrooke\u2019s Cognitive Examination Revised (ACE-R): A brief cognitive test battery for dementia screening","volume":"21","author":"Mioshi","year":"2006","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: Ras a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J. Stat. Softw."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.neurobiolaging.2015.06.028","article-title":"Cerebral amyloid angiopathy and its co-occurrence with Alzheimer\u2019s disease and other cerebrovascular neuropathologic changes","volume":"36","author":"Brenowitz","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","article-title":"Cerebral amyloid angiopathy: A systematic review","volume":"7","author":"Biffi","year":"2011","journal-title":"J. Clin. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1751","DOI":"10.1212\/WNL.0000000000005524","article-title":"Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis","volume":"90","author":"Kim","year":"2018","journal-title":"Neurology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1212\/WNL.0000000000000285","article-title":"Incidence of cerebral microbleeds in preclinical Alzheimer disease","volume":"82","author":"Yates","year":"2014","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/01.wnl.0000210535.20297.ae","article-title":"Prevalence and severity of microbleeds in a memory clinic setting","volume":"66","author":"Cordonnier","year":"2006","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1161\/STROKEAHA.109.558197","article-title":"Patients with Alzheimer disease with multiple microbleeds: Relation with cerebrospinal fluid biomarkers and cognition","volume":"40","author":"Goos","year":"2009","journal-title":"Stroke"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/WNL.0b013e3181b879ac","article-title":"Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease","volume":"73","author":"Henneman","year":"2009","journal-title":"Neurology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3174\/ajnr.A4525","article-title":"Prevalence of Brain Microbleeds in Alzheimer Disease: A Systematic Review and Meta-Analysis on the Influence of Neuroimaging Techniques","volume":"37","author":"Sepehry","year":"2016","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhou, C., Liu, K., Yan, S., and Jin, Y. (2019). Association between cortical superficial siderosis and dementia in patients with cognitive impairment: A meta-analysis. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00008"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1605","DOI":"10.1212\/WNL.0000000000200142","article-title":"Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration","volume":"98","author":"Beaman","year":"2022","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1161\/STROKEAHA.116.014337","article-title":"Progression of Brain Network Alterations in Cerebral Amyloid Angiopathy","volume":"47","author":"Reijmer","year":"2016","journal-title":"Stroke"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.1009","article-title":"Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy","volume":"49","author":"Grabowski","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e207854","DOI":"10.1212\/WNL.0000000000207854","article-title":"Association Between Hippocampal Volumes and Cognition in Cerebral Amyloid Angiopathy","volume":"102","author":"Perosa","year":"2024","journal-title":"Neurology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23969873241260538","DOI":"10.1177\/23969873241260538","article-title":"CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review\/meta-analysis","volume":"13","author":"Theodorou","year":"2024","journal-title":"Eur. Stroke J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000506765","article-title":"Colocalization of Tau but Not \u03b2-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA","volume":"12","author":"Brendel","year":"2020","journal-title":"Case Rep. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"fcae086","DOI":"10.1093\/braincomms\/fcae086","article-title":"Cerebral tau pathology in cerebral amyloid angiopathy","volume":"6","author":"Tsai","year":"2024","journal-title":"Brain Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jnnp-2011-301308","article-title":"Sporadic cerebral amyloid angiopathy revisited: Recent insights into pathophysiology and clinical spectrum","volume":"83","author":"Charidimou","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1474-4422(16)30030-8","article-title":"Cortical atrophy in patients with cerebral amyloid angiopathy: A case-control study","volume":"15","author":"Fotiadis","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/STROKEAHA.110.594267","article-title":"Brain atrophy and cerebral small vessel disease: A prospective follow-up study","volume":"42","author":"Nitkunan","year":"2011","journal-title":"Stroke"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.25123","article-title":"Person-specific contribution of neuropathologies to cognitive loss in old age","volume":"83","author":"Boyle","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1474-4422(14)70003-1","article-title":"Outcome markers for clinical trials in cerebral amyloid angiopathy","volume":"13","author":"Greenberg","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3233\/JAD-160400","article-title":"Cerebrospinal fluid Alzheimer\u2019s disease biomarkers in isolated supratentorial cortical superficial siderosis","volume":"54","author":"Renard","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/WNL.0000000000004539","article-title":"Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nicl.2017.05.002","article-title":"Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update","volume":"15","author":"Farid","year":"2017","journal-title":"Neuroimage Clin."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e209386","DOI":"10.1212\/WNL.0000000000209386","article-title":"Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study","volume":"102","author":"Switzer","year":"2024","journal-title":"Neurology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Tsantzali, I., Foska, A., Sideri, E., Routsi, E., Tsomaka, E., Kitsos, D.K., Zompola, C., Bonakis, A., Giannopoulos, S., and Voumvourakis, K.I. (2022). Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081879"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s10072-023-07258-x","article-title":"Is blood pTau a reliable indicator of the CSF status? A narrative review","volume":"45","author":"Antonioni","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yilmaz, P., Ikram, M.A., Ikram, M.K., Niessen, W.J., Viswanathan, A., Charidimou, A., and Vernooij, M.W. (2019). Application of an Imaging-Based Sum Score for Cerebral Amyloid Angiopathy to the General Population: Risk of Major Neurological Diseases and Mortality. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.01276"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7427\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:48:09Z","timestamp":1760114889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":56,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13237427"],"URL":"https:\/\/doi.org\/10.3390\/jcm13237427","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}